BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 29268191)

  • 21. Montelukast inhibits tumour necrosis factor-alpha-mediated interleukin-8 expression through inhibition of nuclear factor-kappaB p65-associated histone acetyltransferase activity.
    Tahan F; Jazrawi E; Moodley T; Rovati GE; Adcock IM
    Clin Exp Allergy; 2008 May; 38(5):805-11. PubMed ID: 18325031
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Montelukast suppresses the development of irritable bowel syndrome phenotype possibly through modulating NF-κB signaling in an experimental model.
    Khodabakhsh P; Khoie N; Dehpour AR; Abdollahi A; Ghazi-Khansari M; Shafaroodi H
    Inflammopharmacology; 2022 Feb; 30(1):313-325. PubMed ID: 35013876
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TRIB3 mediates the expression of Wnt5a and activation of nuclear factor-κB in Porphyromonas endodontalis lipopolysaccharide-treated osteoblasts.
    Yu Y; Qiu L; Guo J; Yang D; Qu L; Yu J; Zhan F; Xue M; Zhong M
    Mol Oral Microbiol; 2015 Aug; 30(4):295-306. PubMed ID: 25601649
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cysteinyl leukotriene receptor 1 antagonism prevents experimental abdominal aortic aneurysm.
    Di Gennaro A; Araújo AC; Busch A; Jin H; Wågsäter D; Vorkapic E; Caidahl K; Eriksson P; Samuelsson B; Maegdefessel L; Haeggström JZ
    Proc Natl Acad Sci U S A; 2018 Feb; 115(8):1907-1912. PubMed ID: 29432192
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effects of cysteinyl leukotriene receptors on phagocytosis of mouse microglial cells].
    Wang X; Lu Y; Zhang W; Wei E; Fang S
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2018 Jan; 47(1):10-18. PubMed ID: 30146806
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effects of low dose leukotriene receptor antagonist therapy on airway remodeling and cysteinyl leukotriene expression in a mouse asthma model.
    Muz MH; Deveci F; Bulut Y; Ilhan N; Yekeler H; Turgut T
    Exp Mol Med; 2006 Apr; 38(2):109-18. PubMed ID: 16672764
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Montelukast, Leukotriene Inhibitor, Reduces LPS-Induced Acute Lung Inflammation and Human Neutrophil Activation.
    Davino-Chiovatto JE; Oliveira-Junior MC; MacKenzie B; Santos-Dias A; Almeida-Oliveira AR; Aquino-Junior JCJ; Brito AA; Rigonato-Oliveira NC; Damaceno-Rodrigues NR; Oliveira APL; Silva AP; Consolim-Colombo FM; Aimbire F; Castro-Faria-Neto HC; Vieira RP
    Arch Bronconeumol (Engl Ed); 2019 Nov; 55(11):573-580. PubMed ID: 31257011
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Montelukast regulates eosinophil protease activity through a leukotriene-independent mechanism.
    Langlois A; Ferland C; Tremblay GM; Laviolette M
    J Allergy Clin Immunol; 2006 Jul; 118(1):113-9. PubMed ID: 16815146
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antagonism of cysteinyl leukotriene receptor 1 (cysLTR1) by montelukast suppresses cell senescence of chondrocytes.
    Song W; Zhang Y; Wang J; Ma T; Hao L; Wang K
    Cytokine; 2018 Mar; 103():83-89. PubMed ID: 29331588
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of montelukast on nuclear factor kappaB activation and proinflammatory molecules.
    Maeba S; Ichiyama T; Ueno Y; Makata H; Matsubara T; Furukawa S
    Ann Allergy Asthma Immunol; 2005 Jun; 94(6):670-4. PubMed ID: 15984600
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cysteinyl leukotriene receptor 1 regulates glucose-stimulated insulin secretion (GSIS).
    Guo R; Jiang J; Jing Z; Chen Y; Shi Z; Deng B
    Cell Signal; 2018 Jun; 46():129-134. PubMed ID: 29412178
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Paeoniflorin Suppressed High Glucose-Induced Retinal Microglia MMP-9 Expression and Inflammatory Response via Inhibition of TLR4/NF-κB Pathway Through Upregulation of SOCS3 in Diabetic Retinopathy.
    Zhu SH; Liu BQ; Hao MJ; Fan YX; Qian C; Teng P; Zhou XW; Hu L; Liu WT; Yuan ZL; Li QP
    Inflammation; 2017 Oct; 40(5):1475-1486. PubMed ID: 28639050
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The 15-deoxy-Delta12,14-prostaglandin J2 inhibits LPS-stimulated AKT and NF-kappaB activation and suppresses interleukin-6 in osteoblast-like cells MC3T3E-1.
    Jung WK; Park IS; Park SJ; Yea SS; Choi YH; Oh S; Park SG; Choi IW
    Life Sci; 2009 Jul; 85(1-2):46-53. PubMed ID: 19409914
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nitric oxide promotes infectious bone resorption by enhancing cytokine-stimulated interstitial collagenase synthesis in osteoblasts.
    Lin SK; Kok SH; Kuo MY; Lee MS; Wang CC; Lan WH; Hsiao M; Goldring SR; Hong CY
    J Bone Miner Res; 2003 Jan; 18(1):39-46. PubMed ID: 12510804
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sesquiterpene lactone parthenolide blocks lipopolysaccharide-induced osteolysis through the suppression of NF-kappaB activity.
    Yip KH; Zheng MH; Feng HT; Steer JH; Joyce DA; Xu J
    J Bone Miner Res; 2004 Nov; 19(11):1905-16. PubMed ID: 15476591
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cysteinyl leukotriene receptor (CysLT) antagonists decrease pentylenetetrazol-induced seizures and blood-brain barrier dysfunction.
    Lenz QF; Arroyo DS; Temp FR; Poersch AB; Masson CJ; Jesse AC; Marafiga JR; Reschke CR; Iribarren P; Mello CF
    Neuroscience; 2014 Sep; 277():859-71. PubMed ID: 25090924
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sirtuin 1 regulates matrix metalloproteinase-13 expression induced by
    Qu L; Yu Y; Qiu L; Yang D; Yan L; Guo J; Jahan R
    J Oral Microbiol; 2017; 9(1):1317578. PubMed ID: 28473882
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Doxycycline down-regulates matrix metalloproteinase expression and inhibits NF-κB signaling in LPS-induced PC3 cells.
    Ogut D; Reel B; Gonen Korkmaz C; Arun MZ; Cilaker Micili S; Ergur BU
    Folia Histochem Cytobiol; 2016; 54(4):171-180. PubMed ID: 27966209
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SP600125 reduces lipopolysaccharide-induced apoptosis and restores the early-stage differentiation of osteoblasts inhibited by LPS through the MAPK pathway in MC3T3-E1 cells.
    Guo C; Wang SL; Xu ST; Wang JG; Song GH
    Int J Mol Med; 2015 May; 35(5):1427-34. PubMed ID: 25760015
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Montelukast attenuates neuropathic pain through inhibiting p38 mitogen-activated protein kinase and nuclear factor-kappa B in a rat model of chronic constriction injury.
    Zhou C; Shi X; Huang H; Zhu Y; Wu Y
    Anesth Analg; 2014 May; 118(5):1090-6. PubMed ID: 24686047
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.